Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 GBX | -2.86% | +32.68% | -22.29% |
03/05 | Ondine Biomedical shares rise on fundraise to advance Steriwave | AN |
03/05 | Ondine Biomedical to Raise GBP3 Million Via Placing, Subscription | MT |
Business Summary
Number of employees: 18
Sales per Business
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Antimicrobial Photodynamic Therapy
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -73.30% |
Sales per region
GBP in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
93.4
%
| 1 | 97.4 % | 0 | 93.4 % | -74.38% |
Other
6.6
%
| 0 | 2.6 % | 0 | 6.6 % | -33.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Carolyn Cross
FOU | Founder | 62 | 09/96/09 |
Nicolas Loebel
PSD | President | 64 | 01/04/01 |
Bill Kanz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jason Hickok
CTO | Chief Tech/Sci/R&D Officer | - | - |
Roger Andersen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Simon Sinclair
CTO | Chief Tech/Sci/R&D Officer | 52 | 07/21/07 |
Angelika Vance
IRO | Public Communications Contact | - | - |
Tom Dawson
PRN | Corporate Officer/Principal | - | - |
Nikita Parkhaev
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 07/21/07 |
Carolyn Cross
FOU | Founder | 62 | 09/96/09 |
Nicolas Loebel
PSD | President | 64 | 01/04/01 |
Jean Duvall
BRD | Director/Board Member | 63 | 07/21/07 |
Mike Farrar
BRD | Director/Board Member | 64 | 07/21/07 |
Jean Charest
CHM | Chairman | 65 | 08/18/08 |
Junaid Bajwa
BRD | Director/Board Member | 45 | 07/21/07 |
Simon Sinclair
CTO | Chief Tech/Sci/R&D Officer | 52 | 07/21/07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 194,983,407 | 7,499,533 ( 3.846 %) | 0 | 22.43 % |
Stock B | 0 | 225,617,679 | 86,854,210 ( 38.50 %) | 0 |
Company contact information
Ondine Biomedical, Inc.
1100 Melville Street Suite 888
V6E 4A6, Vancouver
+604-669-0555
http://www.ondinebio.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.29% | 19.91M | |
-3.54% | 185B | |
-0.58% | 109B | |
-2.74% | 68.54B | |
+4.84% | 51.74B | |
+10.40% | 45.22B | |
+3.12% | 41.74B | |
+2.87% | 26.69B | |
+4.61% | 26.83B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- OBI Stock
- Company Ondine Biomedical Inc.